Barclays
MLTX icon

Barclays’s MoonLake Immunotherapeutics MLTX Stock Holding History

Barclays’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$515K Sell
27,602
-22,649
-45% -$375K ﹤0.01% 3172
2025
Q4 		$662K Buy
50,251
+50,235
+313,969% +$593K ﹤0.01% 3694
2025
Q3 		$115 Sell
16
-4,537
-100% -$236K ﹤0.01% 5267
2025
Q2 		$215K Sell
4,553
-15,046
-77% -$613K ﹤0.01% 4226
2025
Q1 		$766K Buy
19,599
+14,953
+322% +$644K ﹤0.01% 3268
2024
Q4 		$252K Sell
4,646
-995
-18% -$50.8K ﹤0.01% 4201
2024
Q3 		$284K Buy
5,641
+5,229
+1,269% +$245K ﹤0.01% 4117
2024
Q2 		$18.1K Sell
412
-3,367
-89% -$143K ﹤0.01% 4450
2024
Q1 		$190K Sell
3,779
-2,335
-38% -$127K ﹤0.01% 4142
2023
Q4 		$369K Buy
6,114
+2,802
+85% +$144K ﹤0.01% 4064
2023
Q3 		$189K Buy
+3,312
New +$183K ﹤0.01% 3327
2023
Q1 		– Sell
-55,952
Closed -$587K – 5249
2022
Q4 		$587K Buy
55,952
+40,768
+268% +$363K ﹤0.01% 3206
2022
Q3 		$118K Buy
15,184
+101
+0.7% +$714 ﹤0.01% 3472
2022
Q2 		$79K Buy
+15,083
New +$94.8K ﹤0.01% 3865

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return